EIGER BIOPHARMACEUTICALS INC (EIGR)

US28249U2042 - Common Stock

1.725  -0.17 (-9.21%)

After market: 1.7 -0.03 (-1.45%)

News Image
a month ago - Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

News Image
a month ago - Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April ...

News Image
a month ago - Bloomberg

Eiger Biopharmaceuticals Files for Chapter 11 Bankruptcy

Eiger Biopharmaceuticals Inc., a company developing therapies for rare metabolic diseases, has filed for bankruptcy.

News Image
3 months ago - Eiger BioPharmaceuticals, Inc.

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

News Image
4 months ago - Seeking Alpha

Eiger BioPharmaceuticals announces 1-for-30 reverse stock split (NASDAQ:EIGR)

Eiger BioPharmaceuticals plans a 1-for-30 reverse stock split, effective January 5, with trading on a post-split basis starting January 8.

News Image
4 months ago - Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) (the "Company"), a commercial-stage biopharmaceutical company focused on the development of...

News Image
6 months ago - Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

News Image
8 months ago - BusinessInsider

Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 43.3% to $1.29 in pre-market trading.

News Image
8 months ago - InvestorPlace

Why Is Sigma Lithium (SGML) Stock Up 14% Today?

Sigma Lithium (SGML) stock is climbing higher on Wednesday after confirming it has received multiple strategic proposals.

News Image
8 months ago - InvestorPlace

WKHS Stock Alert: The $40,000 Reason Workhorse Is Up Today

Workhorse (WKHS) stock is on the rise Wednesday thanks to a new update from the IRS concerning its electric vehicle (EV) manufacturer status.